Registry following teenagers with severe alopecia areata during routine care
Tracks safety and effectiveness of treatments in teenagers with severe alopecia areata.
Key facts
- Who runs it
- CorEvitas
- Where
- Waltham, United StatesSee the site
- Trial code
- Registry title
- CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- 7 Mar 2024
- Expected to end
- 31 Dec 2099
- Type of study
- Observational
- Record updated
- 17 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for teenagers aged 12-17 who have ever been diagnosed with severe alopecia areata (patchy hair loss). It is a registry that follows their routine care.
- Age
- 12 to 17 years
- Sex
- All sexes
- Disease stage
- Severe alopecia areata, diagnosed at any time by a dermatologist or a qualified healthcare provider
Main reasons for not taking part
- Taking part, or planning to take part, in a blinded clinical trial of any investigational medicine
- Unwilling or unable to have standing height measured
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- To be eligible to participate in this registry, an individual must meet all the following criteria:
- Has ever been diagnosed with severe AA by a dermatologist or a qualified healthcare provider
- Is 12-17 years of age at the time of enrollment
- Is willing to provide consent/assent for participation in the registry
Who cannot take part
- Is participating or planning to participate in a blinded clinical trial for any investigational medication
- An individual who meets any of the following criteria will be excluded from participation in the registry:
- Is unwilling or unable to provide standing height measurements
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 17 years old?
Where in United States
- CorEvitas, LLCWaltham, United StatesContact: Cathy CheneyTaking people
About the trial
What the trial wants to find out
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
- Plain-language title
- Registry following teenagers with severe alopecia areata during routine careGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06562270, who can take part
- Record updated
- 17 August 2026